Closing of Merger and Financing Transaction (Tables)

9 Months Ended

Sep. 30, 2013

Merger and Financial disclosure [Abstract]

Summary Of Purchase Price

The following table summarizes the purchase price:

Common shares outstanding at the date of merger (in thousands)		61,749
Closing price per share	$	1.52
	$	93,858
Cash consideration		293
Total purchase price	$	94,151

Summary of Business Acquisitions, by Acquisition

The following table summarizes the allocation of the purchase price to the net assets acquired (in thousands):

Cash and cash equivalents	$	597
Accounts receivable		9
Accounts receivable, related party		45
Inventory		50
Other current assets		53
Property and equipment		357
Other long-term asset		2
Intangible assets		10
Goodwill		93,670
Total assets acquired	$	94,793
Accounts payable and other liabilities		642
Total purchase price	$	94,151

Summary of Business Acquisition, Pro Forma Information

The pro forma results of operations presented below may not be indicative of the results the Company would have achieved had the Company completed the acquisition on January 1, 2013, or that the Company may achieve in the future.

					Historical
	SafeStitch Medical, Inc.				Results of		Pro Forma		Pro Forma
	(the Company)		SafeStitch		SafeStitch Medical, Inc		Adjustments		Results
	(in thousands)
Revenue	$	1,212	$	25	$	1,237	$	-	$	1,237
Net loss	$	(20,327)	$	(2,062)	$	(22,389)	$	-	$	(22,389)
Historical TransEnterix loss per     common share - basic     and diluted					$	(0.13)
Pro forma loss per common share -     basic and diluted:					$	(0.13)
Pro forma loss					$	(22,389)
Pro forma weighted average common     shares						167,502
Pro forma loss per common share					$	(0.13)